dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Perkhofer, Lukas |
dc.contributor.author | Golan, Talia |
dc.contributor.author | Cuyle, Pieter-Jan |
dc.contributor.author | Matysiak-Budnik, Tamara |
dc.contributor.author | Van Laethem, Jean-Luc |
dc.contributor.author | Macarulla Mercadé, Teresa |
dc.date.accessioned | 2022-05-11T08:29:15Z |
dc.date.available | 2022-05-11T08:29:15Z |
dc.date.issued | 2021-08-24 |
dc.identifier.citation | Perkhofer L, Golan T, Cuyle PJ, Matysiak-Budnik T, Laethem JL Van, Macarulla T, et al. Targeting DNA Damage Repair Mechanisms in Pancreas Cancer. Cancers 2021. 2021 Aug 24;13(17):4259. |
dc.identifier.issn | 2072-6694 |
dc.identifier.uri | https://hdl.handle.net/11351/7506 |
dc.description | BRCA1/2; Inhibició DE PARP; Adenocarcinoma ductal pancreàtic |
dc.description.sponsorship | This congress paper received no external funding. Additional research funding is declared: L.P. (DFG PE 3337/1-1), A.K. (DFG KL 2544/1-1, 1-2, 5-1, 6-1, 7-1, Baden-Württemberg-Foundation ExPoChip, German Cancer Aid 111879, INDIMED-Verbund PancChip, HEIST RTG DFG GRK 2254/1 and Excellence grant Else-Kröner-Fresenius-Stiftung), E.M.O. (Cancer Center Support Grant/Core Grant P30 CA008748). |
dc.language.iso | eng |
dc.publisher | MDPI |
dc.relation.ispartofseries | Cancers;13(17) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Pàncrees - Càncer - Prognosi |
dc.subject | ADN - Reparació |
dc.subject.mesh | Pancreatic Neoplasms |
dc.subject.mesh | /drug therapy |
dc.subject.mesh | DNA Repair |
dc.subject.mesh | Prognosis |
dc.title | Targeting DNA Damage Repair Mechanisms in Pancreas Cancer |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.3390/cancers13174259 |
dc.subject.decs | neoplasias pancreáticas |
dc.subject.decs | /farmacoterapia |
dc.subject.decs | reparación del ADN |
dc.subject.decs | pronóstico |
dc.relation.publishversion | https://doi.org/10.3390/cancers13174259 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Perkhofer L] Department of Internal Medicine I, Ulm University Hospital, Ulm, Germany. [Golan T] Oncology Institute, Sheba Medical Center, Tel Aviv University, Tel Aviv, Israel. [Cuyle PJ] Digestive Oncology Department, Imelda General Hospital, Bonheiden, Belgium. University Hospitals Gasthuisberg Leuven and KU Leuven, Leuven, Belgium. [Matysiak-Budnik T] IMAD, Department of Gastroenterology and Digestive Oncology, Hôtel Dieu, CHU de Nantes, Nantes, France. [Van Laethem JL] GI Cancer Unit, Erasme Hospital, Université Libre de Bruxelles, Brussels, Belgium. [Macarulla T] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain |
dc.identifier.pmid | 34503069 |
dc.identifier.wos | 000694122200001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |